XFORNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
X4 Pharmaceuticals, Inc
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$2.75+0.16 (+6.18%)
Close on Oct 19, 2026
- Market cap
- $347.45M
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Apr 28, 2025 | 1-for-30 reverse | Earlier per-share figures multiplied by 30 |
| Apr 28, 2025 | 1-for-30 reverse | Earlier per-share figures multiplied by 30 |
| May 15, 2019(first seen in filings) | 1-for-31 reverse | Earlier per-share figures multiplied by 31 |
| Mar 14, 2019 | 1-for-6 reverse | Earlier per-share figures multiplied by 6 |